Page last updated: 2024-10-30

lomefloxacin and Acute Promyelocytic Leukemia

lomefloxacin has been researched along with Acute Promyelocytic Leukemia in 1 studies

lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.

Research Excerpts

ExcerptRelevanceReference
"Lomefloxacin (LFX) is a widely used fluoroquinolone antimicrobial agent that plays an important role in the treatment of human and animal infections; however, it has been reported to cause phototoxicity."1.46Photodynamically-induced Apoptosis Due to Ultraviolet A in the Presence of Lomefloxacin in Human Promyelocytic Leukemia Cells. ( Imaizumi, T; Iwase, Y; Nakai, S; Nishi, K; Okudaira, K; Watanabe, T; Yumita, N, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakai, S1
Imaizumi, T1
Watanabe, T1
Iwase, Y1
Nishi, K1
Okudaira, K1
Yumita, N1

Other Studies

1 other study available for lomefloxacin and Acute Promyelocytic Leukemia

ArticleYear
Photodynamically-induced Apoptosis Due to Ultraviolet A in the Presence of Lomefloxacin in Human Promyelocytic Leukemia Cells.
    Anticancer research, 2017, Volume: 37, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Survival; Combined Modality Therapy; DNA Fragmenta

2017